A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ABP-671
Clinical trial NCT04060173 · COMPLETED
Trial details
- NCT number
- NCT04060173
- Sponsor
- Atom Therapeutics Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-05
- Primary completion
- 2019-12-29
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.